Attached files

file filename
8-K - FORM 8-K - COVENTRY HEALTH CARE INCform8k_10302009.htm

 


 

 

Contact:

Shawn M. Guertin

Chief Financial Officer

(301) 581-5701

 

Drew Asher

SVP, Corporate Finance

(301) 581-5717

 

Coventry Health Care Reports Third Quarter Earnings and Increases Full Year 2009 Guidance

 

GAAP Earnings of $0.48 per Diluted Share; Adjusted Earnings of $0.66 per Diluted Share               

 

BETHESDA, Md. (October 30, 2009) - Coventry Health Care, Inc. (NYSE: CVH) today reported consolidated operating results for the quarter ended September 30, 2009. Operating revenues totaled $3.4 billion for the quarter with GAAP net earnings of $70.6 million, or $0.48 earnings per diluted share (EPS). Excluding the impact of the First Health Services Corporation (FHSC) divestiture in the third quarter, which resulted in a net charge of $26.7 million, or $0.18 per diluted share, adjusted net earnings were $97.3 million, or $0.66 per diluted share.(1)

 

Excluding the impact of the FHSC divestiture, the Company is increasing its full year 2009 adjusted EPS guidance to a range of $2.01 to $2.03, an increase of $0.12 from the midpoint of the prior EPS range of $1.85 to $1.95. GAAP EPS for the full year is now expected to be in a range of $1.45 to $1.47 as the Company has recorded a largely non-cash full year charge of $0.56 per diluted share as a result of the FHSC divestiture, as outlined on page two.

 

“I continue to be pleased with the Company’s financial and operational results for 2009 including today’s increase to full year EPS guidance,” said Allen F. Wise, chairman and chief executive officer of Coventry. “In the face of a challenging environment, we feel confident that focusing on our seven core businesses and driving a low cost structure will best position Coventry for the future.”

 

Third Quarter Consolidated Highlights

Revenues from continuing operations increased 17.7% from the prior year quarter

Continued growth in Medicare products

 

o

Medicare Coordinated Care Product (CCP) membership growth of 38% from the prior year quarter

 

o

Medicare Part D membership growth of 81,000 from the prior quarter

Health plan commercial group risk medical loss ratio of 82.1%

GAAP cash flows from operations were $314.3 million

Excellent liquidity position

 

o

Approximately $570 million of deployable free cash at the parent at quarter-end

 

o

Debt repayment of $98 million during the quarter

Share buyback of 1.5 million shares at the end of the quarter

Investment portfolio in a net unrealized gain position at quarter-end

 

 

1) Adjusted earnings of $0.66 per diluted share include earnings from continuing operations of $0.68 per diluted share and a loss of $0.02 per diluted share from FHSC operations during the quarter. The Company believes that adjusting earnings to exclude the unfavorable impact of the non-recurring FHSC divestiture-related charges provides a more meaningful measure of its operating results in comparison to prior and future periods (and to previously announced guidance). See page two for further details.

 

 

Selected Third Quarter Highlights

 

Health Plan Commercial Group Premium Yield & Medical Loss Ratio (MLR). Reported commercial group risk premium yields rose to $304.13 PMPM (per member per month) in the quarter, an increase of 6.1% from the prior year quarter. The health plan commercial group risk MLR was 82.1% in the quarter, a decrease of 20 basis points from the prior year quarter.

 

Medicare Advantage Membership & MLR. As of September 30, 2009, Medicare Advantage membership was 521,000, an increase of 141,000 members year-to-date. Medicare Advantage CCP membership was 185,000, an increase of 48,000 members year-to-date. The Medicare Advantage MLR was 89.4% in the quarter, a sequential decrease of 100 bps driven by favorable results in Medicare Advantage Private Fee-for-Service (PFFS). The Medicare Advantage PFFS MLR improvement in the third quarter compared to the first half of 2009 contributed approximately $0.07 per diluted share in the quarter. As previously announced, the Company will exit the Medicare Advantage PFFS product effective January 1, 2010.

 

Medicare Part D Membership & MLR. As of September 30, 2009, Medicare Part D membership was 1,636,000, an increase of 81,000 members from the prior quarter and 705,000 members year-to-date. The Medicare Part D MLR was 79.4% in the quarter and 91.9% year-to-date, compared to the third quarter 2008 year-to-date MLR of 91.5%.

 

Medicaid Membership. As of September 30, 2009, Medicaid membership was 391,000, an increase of 6,000 members from the prior quarter. The Medicaid MLR was 86.1% in the quarter.

 

First Health Services Corporation Divestiture. The previously announced divestiture of FHSC closed on July 31, 2009. In accordance with GAAP, the historical FHSC results of operations are classified as discontinued operations and are excluded from consolidated continuing operations for each period presented. In addition to the results of FHSC operations, the discontinued operations for the third quarter and year-to-date periods of 2009 include charges to reflect the impact of the FHSC divestiture. Consistent with previous guidance, in the third quarter of 2009 the Company recorded a primarily non-cash net charge of $0.18 per diluted share to complete the divestiture. When combined with the loss of $0.02 per diluted share generated from FHSC operating results in the quarter, the total EPS from discontinued operations was a loss of $0.20 for the third quarter. Including the previously disclosed $0.38 per diluted share charge recorded in the second quarter, the total year-to-date charge on the FHSC divestiture was $0.56 per diluted share, which is consistent with the lower end of the Company’s prior estimate of $0.55 to $0.60 per diluted share. When combined with the $0.06 of EPS generated from FHSC year-to-date operating results, the total EPS from discontinued operations was a loss of $0.50 for the nine months ended September 30, 2009.

 

 

Mr. Allen F. Wise, chairman and chief executive officer of Coventry, will host a conference call at 8:30 a.m. ET on Friday, October 30, 2009. To listen to the call, dial toll-free at (888) 352-6803 or, for international callers, (719) 325-2474. Callers will be asked to identify themselves and their affiliations. The conference call will also be webcast from Coventry’s Investor Relations site at www.coventryhealthcare.com. Coventry asks participants on both the call and webcast to review and be familiar with its filings with the Securities and Exchange Commission. A replay of the call will be available for one week at (888) 203-1112 or, for international callers, (719) 457-0820. The access code is 3147061.

 

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are defined as statements that are not historical facts and include those statements relating to future events or future financial performance. Actual performance may be significantly impacted by certain risks and uncertainties including those described in Coventry’s Annual Report on Form 10-K for the year ended December 31, 2008 and Coventry’s Form 10-Q for the quarter ended June 30, 2009. Coventry undertakes no obligation to update or revise any forward-looking statements.

 

Coventry Health Care (www.coventryhealthcare.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators.

 

 

COVENTRY HEALTH CARE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands, except per share data)

(unaudited)

 

 

Quarters Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

2009

 

2008

 

2009

 

2008

 

Operating revenues:

 

 

 

 

 

 

 

 

 

Managed care premiums

$3,153,142

 

$2,627,345

 

$9,595,872

 

$7,891,701

 

 

Management services

290,968

 

298,376

 

879,507

 

865,785

 

Total operating revenues

3,444,110

 

2,925,721

 

10,475,379

 

8,757,486

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Medical costs

2,661,131

 

2,200,405

 

8,261,102

 

6,630,950

 

 

Cost of sales

62,384

 

54,289

 

178,280

 

139,038

 

 

Selling, general, administrative

527,173

 

478,973

 

1,607,142

 

1,411,163

 

 

Depreciation and amortization

40,660

 

35,617

 

110,309

 

109,401

 

Total operating expenses

3,291,348

 

2,769,284

 

10,156,833

 

8,290,552

 

 

 

 

 

 

 

 

 

 

 

Operating earnings

152,762

 

156,437

 

318,546

 

466,934

 

Operating earnings percentage of total revenues

4.4%

 

5.3%

 

3.0%

 

5.3%

 

 

 

 

 

 

 

 

 

 

 

Interest expense

20,697

 

22,523

 

64,603

 

70,545

 

Other income, net

18,012

 

(9,904)

 

69,773

 

52,292

 

Earnings before income taxes

150,077

 

124,010

 

323,716

 

448,681

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

49,638

 

45,032

 

117,462

 

168,027

 

Income from continuing operations

100,439

 

78,978

 

206,254

 

280,654

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations, net of tax

(29,810)

 

6,496

 

(73,033)

 

13,000

 

 

 

 

 

 

 

 

 

 

 

Net earnings

$  70,629

 

$  85,474

 

$  133,221

 

$  293,654

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share:

 

 

 

 

 

 

 

 

Basic earnings per share from continuing operations

$      0.68 

 

$      0.54 

 

$      1.40 

 

$      1.88 

 

Basic (loss) earnings per share from discontinued operations

(0.20)

 

0.04 

 

(0.50)

 

0.09 

 

Total basic earnings per share

$     0.48 

 

$      0.58 

 

$      0.90 

 

$      1.96 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share from continuing operations

$     0.68 

 

$      0.53 

 

$      1.40 

 

$      1.86 

 

Diluted (loss) earnings per share from discontinued operations

(0.20)

 

0.04 

 

(0.50)

 

0.09 

 

Total diluted earnings per share

$    0.48 

 

$      0.58 

 

$      0.90 

 

$      1.94 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic

147,062

 

146,652

 

146,956

 

149,591

 

Weighted average shares outstanding, diluted

147,784

 

147,802

 

147,569

 

151,229

 

Page 4 of 8

 

COVENTRY HEALTH CARE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands)

 

 

 

 

September 30,

 

June 30,

 

December 31,

 

 

2009

 

2009

 

2008

 

 

(unaudited)

 

(unaudited)

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

$

1,691,847

$

1,712,152

$

1,123,114

Short-term investments

 

355,417

 

112,677

 

338,129

Accounts receivable, net

 

259,775

 

280,292

 

293,636

Other receivables, net

 

501,348

 

607,359

 

524,803

Other current assets

 

156,837

 

186,651

 

130,808

Total current assets

 

2,965,224

 

2,899,131

 

2,410,490

 

 

 

 

 

 

 

Long-term investments

 

1,888,670

 

1,762,120

 

1,709,878

Property and equipment, net

 

270,153

 

292,690

 

308,016

Goodwill

 

2,535,718

 

2,622,479

 

2,695,025

Other intangible assets, net

 

491,164

 

513,209

 

546,168

Other long-term assets

 

33,949

 

34,430

 

57,821

Total assets

$

8,184,878

$

8,124,059

$

7,727,398

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Medical liabilities

$

1,702,855

$

1,752,969

$

1,446,391

Accounts payable and accrued liabilities

 

630,190

 

499,602

 

474,561

Deferred revenue

 

107,172

 

122,294

 

104,823

Total current liabilities

 

2,440,217

 

2,374,865

 

2,025,775

 

 

 

 

 

 

 

Long-term debt

 

1,708,935

 

1,806,842

 

1,902,472

Other long-term liabilities

 

433,077

 

416,286

 

368,482

Total liabilities

 

4,582,229

 

4,597,993

 

4,296,729

 

 

 

 

 

 

 

Stockholders’ equity

 

3,602,649

 

3,526,066

 

3,430,669

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

$

8,184,878

$

8,124,059

$

7,727,398

 

 

 

 

 

 

 

 

 

 

COVENTRY HEALTH CARE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(unaudited)

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

September 30, 2009

 

September 30, 2009

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

Net earnings

$

70,629 

$

133,221 

Adjustments to earnings:

 

 

 

 

Depreciation and amortization

 

40,981 

 

112,570 

Amortization of stock compensation

 

13,552 

 

37,332 

Loss on disposal of FHSC

 

26,738 

 

81,557 

Gain on repurchase of debt

 

(41)

 

(8,371)

Changes in assets and liabilities:

 

 

 

 

Accounts receivable, net

 

(1,868)

 

11,476 

Medical liabilities

 

(50,036)

 

256,542 

Accounts payable and other accrued liabilities

 

93,173 

 

131,467 

Deferred revenue

 

(11,640)

 

5,831 

Other operating activities

 

132,851 

 

27,218 

Net cash flows from operating activities

 

314,339 

 

788,843 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

Capital expenditures, net

 

(11,623)

 

(34,795)

Payments for investments, net of sales and maturities

 

(331,469)

 

(115,791)

Proceeds from acquisition settlements

 

112 

 

10,197 

Proceeds from FHSC disposal, net

 

115,437 

 

115,437 

Net cash flows from investing activities

 

(227,543)

 

(24,952)

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

Proceeds from issuance of stock

 

615 

 

1,094 

Payments for repurchase of stock

 

(10,018)

 

(11,745)

Repayment of debt

 

(97,910)

 

(184,930)

Excess tax benefit from stock compensation

 

212 

 

423 

Net cash flows from financing activities

 

(107,101)

 

(195,158)

 

 

 

 

 

Net change in cash and cash equivalents for current period

 

(20,305)

 

568,733 

Cash and cash equivalents at beginning of period

 

1,712,152 

 

1,123,114 

Cash and cash equivalents at end of period

$

1,691,847 

$

1,691,847 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and Investments:

 

 

 

 

Cash and cash equivalents

$

1,691,847 

$

1,691,847 

Short-term investments

 

355,417 

 

355,417 

Long-term investments

 

1,888,670 

 

1,888,670 

Total cash and investments

$

3,935,934 

$

3,935,934 

 

 

COVENTRY HEALTH CARE, INC.

SELECTED OPERATING STATISTICS

(Unaudited)

 

 

 

Q3 2009

 

Q2 2009

 

Q1 2009

Total

2008

 

Q4 2008

 

Q3 2008

Membership by Product (000s)

 

 

 

 

 

 

Health Plan Commercial Risk

1,431

1,477

1,501

 

1,575

1,587

Health Plan Commercial ASO

689

697

702

 

714

720

Medicare Advantage CCP

185

182

176

 

137

134

Medicaid Risk

391

385

375

 

371

386

Health Plan Total

2,696

2,741

2,754

 

2,797

2,827

 

 

 

 

 

 

 

Medicare Advantage PFFS

336

329

318

 

243

243

Other National Risk

5

15

21

 

24

27

Other National ASO

567

571

575

 

633

641

Total Medical Membership

3,604

3,656

3,668

 

3,697

3,738

 

 

 

 

 

 

 

Medicare Part D

1,636

1,555

1,501

 

931

910

 

 

 

 

 

 

 

Total Membership

5,240

5,211

5,169

 

4,628

4,648

 

 

 

 

 

 

 

Revenues by Product Type (000s)

 

 

 

 

 

 

Commercial Risk

$1,279,571

$1,310,645

$1,327,221

$5,421,984

$1,364,232

$1,362,956

Commercial Management Services

81,661

83,675

83,810

352,369

97,108

86,672

Medicare Advantage

1,268,592

1,224,011

1,161,590

3,177,244

847,231

825,504

Medicaid Risk

281,146

263,039

260,838

1,087,189

259,926

260,060

Total Health Plan and Medical Services Businesses

2,910,970

2,881,370

2,833,459

10,038,786

2,568,497

2,535,192

 

 

 

 

 

 

 

Medicare Part D

316,654

397,090

484,123

847,702

191,899

170,483

Other Premiums

23,568

23,746

23,957

64,783

22,916

18,937

Other Management Services(2)

211,769

215,468

210,893

826,321

210,406

213,799

Total Specialized Managed Care Businesses(2)

551,991

636,304

718,973

1,738,806

425,221

403,219

 

 

 

 

 

 

 

Total Premiums

3,169,531

3,218,531

3,257,729

10,598,902

2,686,204

2,637,940

Total Management Services(2)

293,430

299,143

294,703

1,178,690

307,514

300,471

Other/Eliminations

(18,851)

(19,300)

(19,537)

(43,365)

(16,976)

(12,690)

Total Revenue(2)

$3,444,110

$3,498,374

$3,532,895

$11,734,227

$2,976,742

$2,925,721

 

 

 

 

 

 

 

Consolidated Coventry

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income % of Revenues(2)

4.4%

2.9%

1.8%

5.0%

4.0%

5.3%

 

 

 

 

 

 

 

SGA % of Revenues(2)

15.3%

15.3%

15.4%

16.5%

17.8%

16.4%

 

 

 

 

 

 

 

Total Medical Liabilities (000s)

$1,428,766

$1,413,243

$1,416,735

 

$1,243,620

$1,209,560

Days in Claims Payable (DCP)

54.78

54.07

55.11

 

54.75

54.94

 

 

 

 

 

 

 

Total Debt (millions)

$   1,708.9

$   1,806.8

$   1,902.6

 

$   1,902.5

$   1,472.3

Total Capital (millions)

$   5,311.6

$   5,332.9

$   5,402.8

 

$   5,333.1

$   4,779.3

Debt to Capital

32.2%

33.9%

35.2%

 

35.7%

30.8%

 

2)

Operating statistics excluding discontinued operations.

 

 

COVENTRY HEALTH CARE, INC.

SELECTED REVENUE AND MEDICAL COST STATISTICS

(Unaudited)

 

 

 

 

Q3 2009

 

Q2 2009

 

Q1 2009

Total

2008

 

Q4 2008

 

Q3 2008

Revenue PMPM

 

 

 

 

 

 

Health Plan Commercial Group Risk

$304.13

$299.79

$296.36

$286.30

$289.71

$286.73

Medicare Advantage(3)

$853.90

$857.05

$860.46

$862.60

$862.79

$856.90

Medicare Part D(4)

$  84.63

$  85.27

$ 84.35

$ 88.34

$  89.16

$  85.64

Medicaid Risk

$239.22

$230.27

$231.93

$208.50

$228.33

$226.08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MLR %

 

 

 

 

 

 

Consolidated Total

84.4%

86.4%

87.4%

84.0%

83.8%

83.8%

 

 

 

 

 

 

 

Health Plan Commercial Group Risk

82.1%

81.7%

80.9%

81.7%

83.2%

82.3%

Medicare Advantage

89.4%

90.4%

90.5%

89.0%

90.9%

88.4%

Medicare Part D

79.4%

89.9%

101.8%

84.1%

58.8%

78.5%

Medicaid Risk

86.1%

90.2%

88.3%

85.3%

85.9%

84.2%

 

 

 

 

 

 

 

 

 

 

3)

Revenue PMPM excludes the impact of revenue ceded to external parties.

 

4)

Revenue PMPM excludes the impact of CMS risk-share premium adjustments and revenue ceded to external parties.